Search
3 results for “Teva Pharmaceuticals USA, Inc., et al.”
| Case | Title | Lower Court | Docketed | Status | Tags | Question Presented |
|---|---|---|---|---|---|---|
| 23-768 | Vanda Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc., et al. | Federal Circuit | 2024-01-17 | Denied | federal-circuit innovation-standard ksr-international-co-v-teleflex KSR-precedent obviousness obviousness-standard patent patent-law predictable-results reasonable-expectation-of-success | Whether obviousness requires a showing of 'predictable' results, as this Court held in KSR, or a mere 'reasonable expectation of success,' as the Fede… |
| 23A344 | Vanda Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc., et al. | Federal Circuit | 2023-10-17 | Presumed Complete | KSR-standard obviousness patent-law pharmaceutical-patents predictable-result prior-art | Whether the Federal Circuit's obviousness analysis complies with the Supreme Court's standard in KSR International Co. v. Teleflex Inc. by requiring t… |
| 18-1289 | Allergan, Inc., et al. v. Teva Pharmaceuticals USA, Inc., et al. | Federal Circuit | 2019-04-10 | Denied | blocking-patent blocking-patent-doctrine commercial-success graham-v-john-deere long-felt-need objective-indicia objective-indicia-of-non-obviousness obviousness patent-law patent-law-doctrine-of-obviousness prior-art | Whether the Federal Circuit erred in holding that objective indicia of non-obviousness may be partially or entirely discounted where the development o… |